Account

New to ADSS? Open an
account now to get started.

OR

Already have an account?

Account

New to ADSS? Open an
account now to get started.

Add funds to your ADSS account

Trending markets
TradingView pricing is indicative
Trends & Analysis
News
FedEx delivers revenue concerns, but shares rise
News
US dollar retreats amid growth concerns
News
Lennar shares rise after quarterly earnings beat
Trends & Analysis
News
FedEx delivers revenue concerns, but shares rise
News
US dollar retreats amid growth concerns
News
Lennar shares rise after quarterly earnings beat

Add funds to your ADSS account

Trending markets
TradingView pricing is indicative

CFDs & spread bets are complex instruments & come with a high risk of losing money rapidly due to leverage. 73% of Retail investor accounts lose money when trading CFDs & spread bets with this provider. You should consider whether you understand how CFDs work & whether you can afford to take the high risk of losing your money.


Account
New to ADSS? Open an
account now to get started.
Open an account Login

News

BioNtech shares spike on strong q4

The news shaping the markets today

Russia announced a ceasefire in Mariupol on Thursday to evacuate civilians. Brent crude declined more than 5% on the news.


South Korea’s industrial production grew 6.5% year-over-year in February, following a revised 4.2% increase a month ago, lending support to the KRW/USD forex pair.


Russia’s unemployment rate fell to a record low of 4.1% in February, from 4.4% in the prior month. However, the RUB/USD pair remained flat in forex trading this morning.


US crude oil inventories declined by 3.449 million barrels in the week ending March 25, marking the steepest decline in the past seven weeks. Despite this, WTI crude oil futures lost more than 6% this morning on hopes of an end to the Ukraine crisis.


Mexico’s unemployment rate eased to 3.7% in February, from 4.4 % in the year-ago month. However, the latest reading was higher than market expectations of 3.6% and exerted pressure on the MXN/USD forex pair.

 

What’s happening: Shares of BioNTech SE gained on Wednesday, after the company reported better-than-expected results for its fiscal fourth quarter.

What happened: BioNTech, the biotech firm that partnered with Pfizer for the covid-19 vaccine, delivered billions of doses last year.

The company also announced a massive share buyback authorisation.

 

How were the results: The Mainz, Germany-based company reported strong growth in both sales and earnings for its fiscal fourth quarter.

  • Sales soared more than more than 1,501% year-on year to around €5.53 billion.
  • Net profits expanded almost 800% to nearly €3.2 billion, versus €367 million in the same quarter in 2020.
  • Earnings per share rose to €12.18 per share, from $1.43 a year ago, significantly beating expectations.

Why it matters:

BioNTech has expanded its clinical trial programme for developing new covid-19 vaccines to provide better protection against the Omicron strain.

The US FDA recently announced the authorisation of a second booster shot of the company’s covid-19 vaccine for older adults and immunocompromised individuals.

BioNTech, along its partner Pfizer, delivered about 2.6 billion doses of their Comirnaty/BNT162b2 around the world last year, which included more than 1 billion doses to the low- and middle-income nations.

As of mid-March 2022, both companies had signed orders for around 2.4 billion doses for 2022.

Following strong earnings in 2021, BioNTech is looking to spend between €1.4 billion and €1.5 billion on R&D this year, which represents a 50% surge over last year’s spending level.

BioNTech said it expects to repurchase ADS shares worth up to $1.5 billion over the next two years and proposed a €2.00 per share special cash dividend. Management guided to covid-19 vaccine sales of between $14.5 billion and $18.9 billion for 2022.

How shares responded: BioNTech’s shares gained 1.4% to close at $174.78 on Wednesday, following the release of quarterly results. The stock has lost around 25% year to date.

 

What to watch: Investors will keep an eye on rising covid-19 cases in China, Europe and other regions around the world and any news of the authorisations of BioNTech’s other covid-19 doses.

The markets today

The British pound will be in focus today ahead of a couple of economic reports from the country

 

Context: The sterling recorded gains against the US dollar, but moved lower versus the euro on Wednesday.

Details: On Tuesday, Russia announced plans to scale back its military operations near the Ukrainian city of Kyiv. However, Russia’s forces bombarded those cities just a day after it pledged to scale down its operations.

The British Retail Consortium reported that major retailers had increased their prices by 2.1% during March, representing the fastest annualised rise since September 2011 and the fifth monthly rise in a row.

Despite these concerns, the GBP/USD was supported by expectations of further rate hikes by the Bank of England in the months ahead. Money markets expect the central bank to boost rates by another 139 basis points by the end of the year.

The GBP/USD forex pair gained around 0.3% to close at $1.3135 on Wednesday. Against the euro, the sterling fell around 0.4%.

London’s FTSE 100 rose 0.55% to close at 7,578.75 on Wednesday, recording gains for the second straight session.

What to watch:

Traders await the release of data on UK’s current account and GDP growth today. The current account deficit, which widened sharply to £24.4 billion in the third quarter, is expected to shrink to £17.6 billion in the fourth quarter. The British economy is projected to grow 6.5% year-over-year in the fourth quarter, following a 7% expansion in the prior period.

Other Markets: US indices closed lower on Wednesday, with the Dow Jones, S&P 500 and Nasdaq 100 down by 0.19%, 0.63% and 1.10%, respectively.

Support & resistances for today

Technical Levels News Sentiment
GBP/USD – 1.3133 and 1.3140 Positive
EUR/GBP – 0.8494 and 0.8498 Positive
WTI Crude Oil – 107.43 and 107.63 Negative
FTSE 100 – 7552.71 and 7564.16 Positive
Nikkei 225 – 28024.09 and 28028.84 Negative

 

Market snapshot

What else to watch today

Germany’s retail sales, unemployment rate and number of unemployed persons, UK’s business investment, France’s consumer price inflation rate, household spending and producer prices, Turkey’s balance of trade and foreign exchange reserves, Italy’s unemployment rate and inflation rate, Spain’s current account, Eurozone’s unemployment rate, South Africa’s producer prices change, balance of trade and SACCI business confidence index, India’s Central government budget value, infrastructure output, external debt and current account, Canada’s CFIB’s business barometer long-term index and GDP growth rate, US Challenger job cuts, personal spending, personal income, personal consumption expenditure price index, initial jobless claims, continuing jobless claims, Chicago PMI and natural gas stocks change, Brazil’s unemployment rate, government budget value and value of loans, Russia’s money supply M2, Argentina’s consumer confidence indicator, as well as Mexico’s government budget value.

ADS Securities London Limited “ADSS” is an execution-only service provider. This material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or investment objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by ADSS that any particular investment, security, transaction or investment strategy is suitable for any specific person. To the extent that any content in this material is construed as investment research, you must note and accept that the content was not prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.  This material may contain links to third party websites, and any content, or use of your personal data by any third party websites is not the responsibility of ADSS or any member of the ADSS Group.


Site by Pink Green
© ADSS 2022


CFDs and Spreadbets are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% of Retail investor accounts lose money when trading CFDs and Spread Bets with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

ADSS is a trading name of ADS Securities London Limited, a company registered in England and Wales with company number 07785265 (VAT Registration Number: 212722447). Registered address 9th Floor, 125 Old Broad Street, London, EC2N 1AR. ADS Securities London Limited is authorised and regulated in the UK by the Financial Conduct Authority (FRN 577453).

The information on this site is not directed at residents of the United States, Canada, EU or any particular country outside the UK, and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law.

All opinions, news, analysis, prices or other information contained on this website are provided as general market commentary and does not constitute investment advice, nor a solicitation or recommendation for you to buy or sell any over-the-counter product or other financial instrument. Please ensure you understand all risks and seek independent advice if necessary.